Combining gene expression and survival profiles of each sample, we use median RPKM of each mRNA to divide patients into high-risk and low-risk groups. By using survival package, Kaplan-Meier curves were designed and log-rank P values were computed for every single gene.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.